SARS-CoV-2 in Neurodegenerative Diseases

SARS-CoV-2 in Neurodegenerative Diseases
Author :
Publisher : Frontiers Media SA
Total Pages : 123
Release :
ISBN-10 : 9782832543818
ISBN-13 : 2832543812
Rating : 4/5 (18 Downloads)

Book Synopsis SARS-CoV-2 in Neurodegenerative Diseases by : Gonzalo Emiliano Aranda-Abreu

Download or read book SARS-CoV-2 in Neurodegenerative Diseases written by Gonzalo Emiliano Aranda-Abreu and published by Frontiers Media SA. This book was released on 2024-01-30 with total page 123 pages. Available in PDF, EPUB and Kindle. Book excerpt:


SARS-CoV-2 in Neurodegenerative Diseases Related Books

SARS-CoV-2 in Neurodegenerative Diseases
Language: en
Pages: 123
Authors: Gonzalo Emiliano Aranda-Abreu
Categories: Science
Type: BOOK - Published: 2024-01-30 - Publisher: Frontiers Media SA

DOWNLOAD EBOOK

COVID-19 in Alzheimer's Disease and Dementia
Language: en
Pages: 352
Authors: P. Hemachandra Reddy
Categories: Medical
Type: BOOK - Published: 2023-04-16 - Publisher: Elsevier

DOWNLOAD EBOOK

COVID-19 in Alzheimer's Disease and Dementia crucially summarizes the current status of the coronavirus in patients suffering from these conditions, describing
Neurodegeneration in Multiple Sclerosis
Language: en
Pages: 233
Authors: M. Filippi
Categories: Medical
Type: BOOK - Published: 2008-02-01 - Publisher: Springer Science & Business Media

DOWNLOAD EBOOK

Written by world-renowned scientists, the volume provides a state-of-the-art on the most recent MRI techniques related to MS, and it is an indispensable tool fo
Neurological and Neuroscientific Evidence in Aged COVID-19 Patients
Language: en
Pages: 231
Authors: Thomas Wisniewski
Categories: Science
Type: BOOK - Published: 2021-12-21 - Publisher: Frontiers Media SA

DOWNLOAD EBOOK

Towards New Therapies for Parkinson's Disease
Language: en
Pages: 410
Authors: David Finkelstein
Categories: Medical
Type: BOOK - Published: 2011-11-02 - Publisher: IntechOpen

DOWNLOAD EBOOK

Parkinson's disease (PD) is characterised clinically by various non-motor and progressive motor symptoms, pathologically by loss of dopamine producing cells and